Recent News

• 06.10.2026 - Fennec Announces Results of Annual Meeting
• 05.21.2026 - Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
• 05.18.2026 - Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.07.2026 - Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026

Recent Filings

• 06.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 144 Report of proposed sale of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2026 - 8-K Current report
• 05.22.2026 - EX-99.1 EX-99.1
• 05.18.2026 - EX-99.1 EX-99.1